InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Jacquelyn L Sumer
24 Feb 2026
Chief Legal Officer
Sell
3,601
$14.47
$52.11K
Jeffrey Alan Jones
24 Feb 2026
Chief Medical Officer
Sell
4,582
$14.47
$66.30K
Nadim Ahmed
24 Feb 2026
President and CEO
Sell
13,515
$14.47
$195.56K
Mary Kay Fenton
20 Feb 2026
Chief Financial Officer
Sell
4,398
$13.62
$59.90K
Nadim Ahmed
20 Feb 2026
President and CEO
Sell
16,381
$13.62
$223.11K
Jacquelyn L Sumer
20 Feb 2026
Chief Legal Officer
Sell
3,742
$13.62
$50.97K
Jeffrey Alan Jones
20 Feb 2026
Chief Medical Officer
Sell
4,982
$13.62
$67.85K
Jennifer Michaelson
12 Feb 2026
Chief Scientific Officer
Sell
416
$12.03
$5.00K
Nadim Ahmed
23 Dec 2025
President and CEO
Sell
9,922
$10.01
$99.32K
Jennifer Michaelson
18 Dec 2025
Chief Scientific Officer
Sell
2,898
$9.67
$28.02K
Jeffrey Alan Jones
18 Dec 2025
Chief Medical Officer
Sell
4,632
$9.67
$44.79K
Jacquelyn L Sumer
18 Dec 2025
Chief Legal Officer
Sell
3,480
$9.67
$33.65K
Show all 28 transactions →

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 8
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 184,288
History held since 11 Jan 2021